Notch activation promotes bone metastasis via SPARC inhibition in adenoid cystic carcinoma

Ye Zhang1,2,3, Xiaoxiao Liu1,2,3, Lijing Zhu1,2,3

  • 1Department of Oral Pathology, Peking University School and Hospital of Stomatology, Beijing, China.

Oral Diseases
|March 23, 2023
PubMed
Abstract

Insights

Notch pathway activation in adenoid cystic carcinoma (AdCC) promotes bone metastasis by inhibiting SPARC. SPARC shows potential as a therapeutic target and prognostic biomarker for AdCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Adenoid cystic carcinoma (AdCC) is prone to bone metastasis.
  • The Notch signaling pathway plays a role in cancer progression.
  • SPARC (secreted protein acidic and rich in cysteine) is implicated in bone remodeling.

Purpose of the Study:

  • To investigate the role of Notch signaling pathway dysregulation in AdCC bone metastasis.
  • To determine if SPARC is a potential therapeutic target in AdCC with Notch dysregulation.

Main Methods:

  • Retrospective study of 144 AdCC patients.
  • RNA-sequencing and immunohistochemistry on AdCC samples.
  • In vitro assays assessing cell proliferation, migration, and osteoclast differentiation in NICD-overexpressing cells.

Main Results:

  • Notch pathway activation correlated with down-regulation of SPARC in AdCC.
  • Overexpression of Notch intracellular domain (NICD) promoted AdCC cell growth, migration, and osteoclast differentiation.
  • Exogenous SPARC partially reversed the pro-metastatic effects of NICD.

Conclusions:

  • Notch activation in AdCC contributes to bone metastasis via SPARC inhibition.
  • SPARC may serve as a prognostic biomarker for AdCC.
  • SPARC represents a potential therapeutic target for AdCC with Notch pathway dysregulation.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K